Related Experiment Video
Updated: Jun 3, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
When von Willebrand disease comes into age - a matter of change?
Wolfgang Miesbach1, Erik Berntorp
1Medical Clinic III, Institute of Transfusion Medicine, Goethe University, Frankfurt, Germany. wolfgang.miesbach@kgu.de
Abstract:
The population of elderly patients with von Willebrand Disease (VWD) is growing because of the improvement of medical care. The increase in comorbidities and their treatment as well as standard preventive measures like antiplatelet or anticoagulation therapy constitutes a challenge in the overall treatment of patients with coagulation disorders. Because of the lack of literature on older patients with VWD, we discuss different aspects related to ageing in those patients. Plasma levels of von Willebrand factor and factor VIII, bleeding symptoms, treatment requirements and comorbidities are possibly changing with age. Development of an evidence-based approach to the management of ageing VWD patients is therefore necessary.
Related Concept Videos
Mitral Stenosis I: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Effect of Aging on Tissues
Anticoagulant Drugs: Low-Molecular-Weight Heparins

